Trial intelligence / Profile preview

Biological Standardization of Chenopodium Album Allergen Extract

NCT01675349Phase 2Completed

Sponsor
LETI Pharma
Start
Nov 2012
Primary completion
May 2014
Modality
Allergy Immunotherapy
Countries
1
01

Overview

A Phase 2 trial of chenopodium album allergen extract in Chenopodium album allergy, sponsored by LETI Pharma. Started Nov 2012; status: completed.

02

Drugs

chenopodium album allergen extract
03

Conditions

Chenopodium album allergy

Beyond the preview

Go deeper on NCT01675349.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01675349.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call